Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP829061.RAYLb61RdzDC8gKNzYsfdjb0pZ5HDkLPPuVyzhNKJpcvA130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829061.RAYLb61RdzDC8gKNzYsfdjb0pZ5HDkLPPuVyzhNKJpcvA130_provenance.
• NP226237.RALBy8zm7cR-DeoD08cAL_4Fhr08-VkU53YD7qy4Sy7vs130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226237.RALBy8zm7cR-DeoD08cAL_4Fhr08-VkU53YD7qy4Sy7vs130_provenance.
• NP907959.RAa2hLIOyvse3UwFyfLkRlcEV5CgfOCzc_NhWxZ_EtIaw130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907959.RAa2hLIOyvse3UwFyfLkRlcEV5CgfOCzc_NhWxZ_EtIaw130_provenance.
• NP565127.RArdeI2NBCl3ABT0SGMOBUAs2vALJRdp7VuEEIAso8sic130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565127.RArdeI2NBCl3ABT0SGMOBUAs2vALJRdp7VuEEIAso8sic130_provenance.
• NP430961.RAfqmvv62Cl5Yhdi0koaX0kOEgTbccNf96V2oOG_xywe8130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430961.RAfqmvv62Cl5Yhdi0koaX0kOEgTbccNf96V2oOG_xywe8130_provenance.
• NP397630.RA5YmRxy5_DEf--dkMiUDTFlrO2eWAPAtx23BujFXuRgA130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397630.RA5YmRxy5_DEf--dkMiUDTFlrO2eWAPAtx23BujFXuRgA130_provenance.
• NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_provenance.
• NP122344.RAZDW3YiAdKwrc8CHPEujHMWm7ofvNFOMiqc4_oSrHBEw130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122344.RAZDW3YiAdKwrc8CHPEujHMWm7ofvNFOMiqc4_oSrHBEw130_provenance.
• NP803824.RAx7kyFpJrAAyiT-tVA2xUpQ4f-8Tc5iyTmZhNIJg_okU130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803824.RAx7kyFpJrAAyiT-tVA2xUpQ4f-8Tc5iyTmZhNIJg_okU130_provenance.
• NP852909.RA186RGxBAfKfM9sw-Uw_4gZpA3XVZo9Y-1xTUzFBOrdE130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852909.RA186RGxBAfKfM9sw-Uw_4gZpA3XVZo9Y-1xTUzFBOrdE130_provenance.
• NP964946.RAY8EtJlQz-zVacf5A3TOfC4QbJ7tKJBc-pPkyFVugz3Q130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964946.RAY8EtJlQz-zVacf5A3TOfC4QbJ7tKJBc-pPkyFVugz3Q130_provenance.
• assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP695443.RAJEeQB71UrscXYRSRLRs5WaOdtlcIxiaH3OCBe0M4Zpo130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP695443.RAJEeQB71UrscXYRSRLRs5WaOdtlcIxiaH3OCBe0M4Zpo130_provenance.
• NP910099.RAF0_ULXqxrF6Oij_YoH0xEMp7KKaOGCYfzNxAK9iwnEk130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP910099.RAF0_ULXqxrF6Oij_YoH0xEMp7KKaOGCYfzNxAK9iwnEk130_provenance.
• NP740153.RAXHc1XWq2yZPW81uLU6hUvJCxQQVeVqlRIfFPH1Qh-10130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740153.RAXHc1XWq2yZPW81uLU6hUvJCxQQVeVqlRIfFPH1Qh-10130_provenance.
• NP147794.RAjJGTAG5NCEWq-uvx6QDUdyVSOJ4yePelkbjP6gGEpK0130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147794.RAjJGTAG5NCEWq-uvx6QDUdyVSOJ4yePelkbjP6gGEpK0130_provenance.
• NP740155.RAr92QoEqhJvfu7vj0XJhHUA2mtNd7nvL9-kAG10lCwbs130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740155.RAr92QoEqhJvfu7vj0XJhHUA2mtNd7nvL9-kAG10lCwbs130_provenance.
• NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_provenance.
• NP740382.RAHtWCazfUgdROvxb6DMaCvJDhX9ixw68amlXdw4L6pK4130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740382.RAHtWCazfUgdROvxb6DMaCvJDhX9ixw68amlXdw4L6pK4130_provenance.
• NP147793.RAMXyxQBvSjEAkxImoS2YUR0ziMjXfik05yg44ApyyHiY130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147793.RAMXyxQBvSjEAkxImoS2YUR0ziMjXfik05yg44ApyyHiY130_provenance.